No abstract available
MeSH terms
-
Alemtuzumab
-
Animals
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal / immunology
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Neoplasm
-
Antigens, CD / immunology
-
Antigens, Neoplasm / immunology
-
CD52 Antigen
-
Drug Design
-
Glycoproteins / antagonists & inhibitors*
-
Glycoproteins / immunology
-
Graft vs Host Disease / drug therapy*
-
Graft vs Host Disease / immunology
-
Graft vs Host Disease / prevention & control*
-
Humans
-
Immunosuppression Therapy / adverse effects
-
Immunosuppression Therapy / methods*
-
Infections / chemically induced
-
Infections / immunology
-
Infections / physiopathology
-
Lymphocytes / drug effects*
-
Lymphocytes / immunology
-
Male
-
Mammals / immunology
-
Rats
-
Spermatozoa / immunology
-
Stem Cell Transplantation / adverse effects*
-
Stem Cell Transplantation / methods
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Neoplasm
-
Antigens, CD
-
Antigens, Neoplasm
-
CD52 Antigen
-
CD52 protein, human
-
Cd52 protein, rat
-
Glycoproteins
-
Alemtuzumab